Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3462)
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
5,967
Price
$4.91
Total Value
$29.30K
Shares Held After
613,029
% of Holdings
1.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,879
Price
$4.91
Total Value
$9.23K
Shares Held After
160,087
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,038
Price
$4.91
Total Value
$5.10K
Shares Held After
92,834
% of Holdings
1.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
1,521
Price
$4.91
Total Value
$7.47K
Shares Held After
96,387
% of Holdings
1.6%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
371
Price
$21.36
Total Value
$7.93K
Shares Held After
15,150
% of Holdings
2.4%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
415
Price
$20.52
Total Value
$8.51K
Shares Held After
15,521
% of Holdings
2.6%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
265
Price
$21.36
Total Value
$5.66K
Shares Held After
82,027
% of Holdings
0.3%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
293
Price
$20.51
Total Value
$6.01K
Shares Held After
82,292
% of Holdings
0.4%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
377
Price
$21.36
Total Value
$8.05K
Shares Held After
24,681
% of Holdings
1.5%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
420
Price
$20.52
Total Value
$8.62K
Shares Held After
25,058
% of Holdings
1.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
24,925
Price
$4.81
Total Value
$119.89K
Shares Held After
401,891
% of Holdings
5.8%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
829
Price
$67.99
Total Value
$56.36K
Shares Held After
79,115
% of Holdings
1.0%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
6,500
Price
$8.01
Total Value
$52.06K
Shares Held After
151,588
% of Holdings
4.1%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
2,940
Price
$34.71
Total Value
$102.05K
Shares Held After
80,277
% of Holdings
3.5%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Burns James William — Chief Legal Officer
Shares
3,280
Price
$34.71
Total Value
$113.85K
Shares Held After
49,306
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$571.65
Total Value
$68.60K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$569.75
Total Value
$68.37K
Shares Held After
18,996
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$567.95
Total Value
$227.18K
Shares Held After
19,116
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
323
Price
$566.82
Total Value
$183.08K
Shares Held After
19,516
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
742
Price
$565.99
Total Value
$419.97K
Shares Held After
19,839
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,201
Price
$564.82
Total Value
$1.24M
Shares Held After
20,581
% of Holdings
9.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
896
Price
$563.86
Total Value
$505.22K
Shares Held After
22,782
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
555
Price
$563.00
Total Value
$312.46K
Shares Held After
23,678
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
571
Price
$561.75
Total Value
$320.76K
Shares Held After
24,233
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
72
Price
$560.39
Total Value
$40.35K
Shares Held After
24,804
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
240
Price
$559.03
Total Value
$134.17K
Shares Held After
24,876
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
720
Price
$558.11
Total Value
$401.84K
Shares Held After
25,116
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
977
Price
$557.05
Total Value
$544.23K
Shares Held After
25,836
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
844
Price
$556.17
Total Value
$469.41K
Shares Held After
26,813
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
778
Price
$555.22
Total Value
$431.96K
Shares Held After
27,657
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
401
Price
$553.99
Total Value
$222.15K
Shares Held After
28,435
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$551.86
Total Value
$22.07K
Shares Held After
28,836
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$571.66
Total Value
$68.60K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$570.05
Total Value
$45.60K
Shares Held After
40,633
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$568.53
Total Value
$68.22K
Shares Held After
40,713
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
308
Price
$567.70
Total Value
$174.85K
Shares Held After
40,833
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$566.39
Total Value
$322.84K
Shares Held After
41,141
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
811
Price
$565.38
Total Value
$458.52K
Shares Held After
41,711
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,918
Price
$564.55
Total Value
$1.08M
Shares Held After
42,522
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$563.52
Total Value
$487.45K
Shares Held After
44,440
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
378
Price
$562.49
Total Value
$212.62K
Shares Held After
45,305
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$561.60
Total Value
$320.11K
Shares Held After
45,683
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$559.98
Total Value
$22.40K
Shares Held After
46,253
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$558.51
Total Value
$245.74K
Shares Held After
46,293
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$557.40
Total Value
$434.77K
Shares Held After
46,733
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
808
Price
$556.52
Total Value
$449.67K
Shares Held After
47,513
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,058
Price
$555.41
Total Value
$587.62K
Shares Held After
48,321
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
394
Price
$554.45
Total Value
$218.46K
Shares Held After
49,379
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
175
Price
$553.50
Total Value
$96.86K
Shares Held After
49,773
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
65
Price
$552.25
Total Value
$35.90K
Shares Held After
49,948
% of Holdings
0.1%
Showing 151–200 of 3462 transactions (page 4 of 70)